BMC Cancer

Papers
(The H4-Index of BMC Cancer is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Clinical effects of curcumin in enhancing cancer therapy: A systematic review184
Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis108
Gut microbiome and its role in colorectal cancer103
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protoc82
Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review80
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis78
Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review77
Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis74
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial73
Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program71
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma68
Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model68
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma67
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)66
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients66
Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling65
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma64
Association between heavy metals and colon cancer: an ecological study based on geographical information systems in North-Eastern Iran63
Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis62
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer61
Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up60
Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis59
PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial58
Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases57
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis57
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis57
Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis57
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target55
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells54
Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody50
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer50
Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer49
Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis49
Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis49
Prognosis of pregnancy-associated breast cancer: a meta-analysis49
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review48
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 201948
Fusobacterium nucleatum and oral cancer: a critical review47
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study47
A convolutional neural network-based system to classify patients using FDG PET/CT examinations46
Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression46
Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon45
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma45
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications44
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results44
Tumor mutational burden is associated with poor outcomes in diffuse glioma44
Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status44
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma44
0.053343057632446